Cargando…

Development of a 5-Gene Signature to Evaluate Lung Adenocarcinoma Prognosis Based on the Features of Cancer Stem Cells

Cancer stem cells (CSCs) can induce recurrence and chemotherapy resistance of lung adenocarcinoma (LUAD). Reliable markers identified based on CSC characteristic of LUAD may improve patients' chemotherapy response and prognosis. OCLR was used to calculate mRNA expression-based stemness index (m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wan, Renping, Liao, Hongliang, Liu, Jingting, Zhou, Lin, Yin, Yingqiu, Mu, Tianhao, Wei, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036162/ https://www.ncbi.nlm.nih.gov/pubmed/35480140 http://dx.doi.org/10.1155/2022/4404406

Ejemplares similares

Mutational status of main driver genes influences the prognosis of stage I–III lung adenocarcinoma patients underwent radical surgery
por: Liao, Hongliang, et al.
Publicado: (2021)

LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating the FOSL2/NAMPT axis
por: Chen, Huiyong, et al.
Publicado: (2023)

Identification of Four Genes as Prognosis Signatures in Lung Adenocarcinoma Microenvironment
por: Yao, Yan, et al.
Publicado: (2021)

Identification of 4 immune cells and a 5-lncRNA risk signature with prognosis for early-stage lung adenocarcinoma
por: Mu, Lan, et al.
Publicado: (2021)

Metabolic and senescence characteristics associated with the immune microenvironment in non-small cell lung cancer: insights from single-cell RNA sequencing
por: Liao, Hongliang, et al.
Publicado: (2023)

Identification and validation of GABA‐driven subtypes and prognosis signature of lung adenocarcinoma
por: Li, Lifeng, et al.
Publicado: (2023)

A novel glycosyltransferase-related lncRNA signature correlates with lung adenocarcinoma prognosis
por: Bian, Chengyu, et al.
Publicado: (2022)

A Novel Cancer Stemness-Related Signature for Predicting Prognosis in Patients with Colon Adenocarcinoma
por: Wang, Wei, et al.
Publicado: (2021)

SIRT1 expression is associated with poor prognosis of lung adenocarcinoma
por: Li, Chong, et al.
Publicado: (2015)

Identification and experimental verification of an anoikis and immune related signature in prognosis for lung adenocarcinoma
por: Zhang, Jia-Le, et al.
Publicado: (2023)

Cuproptosis-related gene signatures for predicting prognosis of lung adenocarcinoma
por: Ye, Wei, et al.
Publicado: (2022)

Comprehensive molecular analyses of a TNF family-based signature with regard to prognosis, immune features, and biomarkers for immunotherapy in lung adenocarcinoma
por: Zhang, Chaoqi, et al.
Publicado: (2020)

Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
por: Hua, Linbin, et al.
Publicado: (2023)

An individualized gene expression signature for prediction of lung adenocarcinoma metastases
por: Qi, Lishuang, et al.
Publicado: (2017)

Clinical and functional significance of a novel ferroptosis‐related prognosis signature in lung adenocarcinoma
por: Wang, Ziqi, et al.
Publicado: (2021)

miR-454-3p inhibits non-small cell lung cancer cell proliferation and metastasis by targeting TGFB2
por: Liao, Hongliang, et al.
Publicado: (2021)

Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma
por: Song, Qian, et al.
Publicado: (2019)

Establishment of a Gene Signature to Predict Prognosis for Patients with Lung Adenocarcinoma
por: Li, Zhaodong, et al.
Publicado: (2020)

Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis
por: Huang, Hua, et al.
Publicado: (2022)

An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinoma
por: Chen, Hongquan, et al.
Publicado: (2022)

Identification of cuproptosis-related gene signature to predict prognosis in lung adenocarcinoma
por: Lv, Yanju, et al.
Publicado: (2022)

Development and validation of an immune‐related gene signature for prognosis in Lung adenocarcinoma
por: Guo, Zehuai, et al.
Publicado: (2023)

Lipid metabolism-related gene signatures for predicting the prognosis of lung adenocarcinoma
por: Cao, Xueting, et al.
Publicado: (2023)

Identifying the EMT-related signature to stratify prognosis and evaluate the tumor microenvironment in lung adenocarcinoma
por: Li, Feng, et al.
Publicado: (2022)

Cuproptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of early-stage lung adenocarcinoma patients
por: Tang, Yu, et al.
Publicado: (2022)

A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma
por: Lu, Yinliang, et al.
Publicado: (2022)

Identification of mRNA Signature for Predicting Prognosis Risk of Rectal Adenocarcinoma
por: Jiang, Linlin, et al.
Publicado: (2022)

CT radiomics model combined with clinical and radiographic features for discriminating peripheral small cell lung cancer from peripheral lung adenocarcinoma
por: Wang, Jingting, et al.
Publicado: (2023)

A Novel Mitochondrial-Related Gene Signature for the Tumor Immune Microenvironment Evaluation and Prognosis Prediction in Lung Adenocarcinoma
por: Li, Yin-ping, et al.
Publicado: (2022)

Exploration of a Novel Circadian miRNA Pair Signature for Predicting Prognosis of Lung Adenocarcinoma
por: Yin, Zhengrong, et al.
Publicado: (2022)

A predictive molecular signature consisting of lncRNAs associated with cellular senescence for the prognosis of lung adenocarcinoma
por: Liu, Anbang, et al.
Publicado: (2023)

Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinoma
por: Zhou, Meng, et al.
Publicado: (2016)

Prognostic signature of lipid metabolism associated LncRNAs predict prognosis and treatment of lung adenocarcinoma
por: Zhao, Jie, et al.
Publicado: (2022)

Development of somatic mutation signatures for risk stratification and prognosis in lung and colorectal adenocarcinomas
por: Menor, Mark, et al.
Publicado: (2019)

Development and Validation of a Seven-Gene Signature for Predicting the Prognosis of Lung Adenocarcinoma
por: Zhang, Yingqing, et al.
Publicado: (2020)

Establishment of Immune-related Gene Pair Signature to Predict Lung Adenocarcinoma Prognosis
por: Jiang, Xueping, et al.
Publicado: (2020)

Microenvironment Analysis of Prognosis and Molecular Signature of Immune-Related Genes in Lung Adenocarcinoma
por: Ling, Bo, et al.
Publicado: (2021)

An Inflammation-Related Nine-Gene Signature to Improve Prognosis Prediction of Lung Adenocarcinoma
por: Liu, Ze-jing, et al.
Publicado: (2021)

Establishment of a ferroptosis-related gene signature for prognosis in lung adenocarcinoma patients
por: Cai, Jingjing, et al.
Publicado: (2021)

A Novel Immune-Related Gene Signature Predicts Prognosis of Lung Adenocarcinoma
por: Ma, Chao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7d48qhmim075k1qeed79g3cq2i